Abstract
No public abstract is available from the verified source records.
Annie B. Leamon, Peter C. Hou
Abstract
Authors
Institutions
Provenance
crossref
Confidence 100%
pubmed
Confidence 98%
europepmc
Confidence 96%
openalex
Confidence 95%
datacite
Confidence 0%
No local reference links have been materialized yet.
No local citing links have been materialized yet.
Health care provider knowledge regarding alpha-gal syndrome—United States, March–May 2022
10.15585/mmwr.mm7230a1 · 2023
The immunology of alpha-gal syndrome: history, tick bites, IgE, and delayed anaphylaxis to mammalian meat
10.1111/imr.70035 · 2025
Tick bite as a risk factor for alpha-gal–specific immunoglobulin E antibodies and development of alpha-gal syndrome
10.1016/j.anai.2022.11.021 · 2023
Diagnosis & management of alpha-gal syndrome: lessons from 2,500 patients
10.1080/1744666x.2020.1782745 · 2020
Diagnosis and management of patients with the α-gal Syndrome
10.1016/j.jaip.2019.09.017 · 2020
A retrospective evaluation of heparin product reactions in patients with alpha-gal allergies
10.1016/j.ttbdis.2021.101869 · 2022
Acute hypersensitivity reaction to crotalidae polyvalent immune Fab (CroFab) as initial presentation of galactose-α-1,3-galactose (α-gal) allergy
10.1080/15563650.2017.1313981 · 2017
Prevalence of adverse drug reactions: comparing crotalidae immune polyvalent antivenoms F(ab’) 2 and F(ab) in a galactose-alpha-1,3-galactose (alpha-gal) endemic area
10.1016/j.annemergmed.2025.06.618 · 2026
Prevalence of adverse drug reactions: comparing crotalidae immune polyvalent antivenoms F(ab’) 2 and F(ab) in a galactose-alpha-1,3-galactose (alpha-gal) endemic area
10.1016/j.annemergmed.2025.06.618 · doi-reference
Acute hypersensitivity reaction to crotalidae polyvalent immune Fab (CroFab) as initial presentation of galactose-α-1,3-galactose (α-gal) allergy
10.1080/15563650.2017.1313981 · doi-reference
A retrospective evaluation of heparin product reactions in patients with alpha-gal allergies
10.1016/j.ttbdis.2021.101869 · doi-reference
Diagnosis and management of patients with the α-gal Syndrome
10.1016/j.jaip.2019.09.017 · doi-reference
Diagnosis & management of alpha-gal syndrome: lessons from 2,500 patients
10.1080/1744666x.2020.1782745 · doi-reference
Tick bite as a risk factor for alpha-gal–specific immunoglobulin E antibodies and development of alpha-gal syndrome
10.1016/j.anai.2022.11.021 · doi-reference
The immunology of alpha-gal syndrome: history, tick bites, IgE, and delayed anaphylaxis to mammalian meat
10.1111/imr.70035 · doi-reference
Health care provider knowledge regarding alpha-gal syndrome—United States, March–May 2022
10.15585/mmwr.mm7230a1 · doi-reference